Nexien BioPharma, Inc. (NXEN)
OTCMKTS · Delayed Price · Currency is USD
0.0150
0.00 (0.00%)
Jun 3, 2025, 8:00 PM EDT

Nexien BioPharma Statistics

Total Valuation

NXEN has a market cap or net worth of 1.03 million. The enterprise value is 1.39 million.

Market Cap 1.03M
Enterprise Value 1.39M

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

NXEN has 70.77 million shares outstanding. The number of shares has increased by 8.06% in one year.

Current Share Class 70.77M
Shares Outstanding 70.77M
Shares Change (YoY) +8.06%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) 28.97%
Owned by Institutions (%) n/a
Float 26.27M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio -2.28
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -7.41
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio 0.02
Quick Ratio 0.02
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.70

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -655.83%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 26.26%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -45.85% in the last 52 weeks. The beta is -0.68, so NXEN's price volatility has been lower than the market average.

Beta (5Y) -0.68
52-Week Price Change -45.85%
50-Day Moving Average 0.01
200-Day Moving Average 0.01
Relative Strength Index (RSI) 89.13
Average Volume (20 Days) 6,338

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -118,322
Pretax Income -188,082
Net Income -188,082
EBITDA n/a
EBIT -118,322
Earnings Per Share (EPS) -0.00
Full Income Statement

Balance Sheet

The company has 8,285 in cash and 375,375 in debt, giving a net cash position of -367,090 or -0.01 per share.

Cash & Cash Equivalents 8,285
Total Debt 375,375
Net Cash -367,090
Net Cash Per Share -0.01
Equity (Book Value) -450,516
Book Value Per Share -0.01
Working Capital -450,516
Full Balance Sheet

Cash Flow

Operating Cash Flow -61,782
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NXEN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.06%
Shareholder Yield n/a
Earnings Yield -18.33%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a